Most Active by Volume: 2/22/2012, 04:05 PM

Company	Last Sale	Change Net / %
BAC	$ 7.95	0.16 1.97%
SIRI	$ 2.09	0.03 1.42%
INTC	$ 26.73	0.43 1.58%
DELL	$ 17.15	1.06 5.82%
MSFT	$ 31.27	0.17 0.54%
F	$ 12.28	0.25 2.00%
QQQ	$ 63.33	0.28 0.44%
GE	$ 19.39	0.02 0.10%

View more in Most Active

Most Popular Stories

Brought to you by eLearners.com

ProMetic Life Sciences Receives C$2.5 Mln Purchase Order From Octapharma

(RTTNews.com) - ProMetic Life Sciences Inc. (PLI.TO) announced that it has received a $2.5 million purchase order under its ongoing supply agreement with Octapharma, a Swiss based, independent global plasma fractionation company that specializes in human proteins.

The company stated that this purchase order further confirms the binding forecast received from Octapharma and is in addition to the $0.73 million order announced in October 2011. More than $3.0 million of shipments to Octapharma are expected during the first half of 2012.

This order relates to the purchase of PrioClear, a proprietary prion capture resin incorporated into Octapharma's manufacturing process for its solvent/detergent treated plasma product, Octaplas(R)LG.

For comments and feedback: contact editorial@rttnews.com

http://www.rttnews.com